Survadapt-Webinar_2014_SLIDES D1 design and analysis approaches to evaluate cardiovascular risk - 2012 eugm Adaptive Drug Development Programs for Phases 2 and 3 in Neuropathic Pain - 2011 isbs Designing Adaptive Programs for Neuropathic Pain and the Product Revenue implications_2011 dia D5 efficacy endpoints in oncology D6 transforming oncology development with adaptive studies - 2011-04 E00 program-level modeling and simulation experiences 
